skip to main content
Idioma:
Result Number Material Type Add to My Shelf Action Record Details and Options
1
1547PD - G-CSF as Secondary Prophylaxis of Chemotherapy-Induced Neutropenia in Patients with Solid Tumors: Results of a Prospective, Observational Study
1547PD - G-CSF as Secondary Prophylaxis of Chemotherapy-Induced Neutropenia in Patients with Solid Tumors: Results of a Prospective, Observational Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

1547PD - G-CSF as Secondary Prophylaxis of Chemotherapy-Induced Neutropenia in Patients with Solid Tumors: Results of a Prospective, Observational Study

Freyer, G. ; Jovenin, N. ; Yazbek, G. ; Villanueva, C.B. ; Hussain, A. ; Bethune, A. ; Rotarski, M. ; Simon, H. ; Boulanger, V. ; Hummerlsberger, M.

Annals of oncology, 2012-09, Vol.23, p.ix499-ix500 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
2
203 Urine biomarkers for prostate cancer
203 Urine biomarkers for prostate cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

203 Urine biomarkers for prostate cancer

Yazbek, Hanna M ; Clark, J ; Hurst, R ; Brewer, D ; McCarthy, F ; Mills, R ; Rochester, M ; Edwards, D ; Cooper, C

European urology supplements : official journal of the European Association of Urology, 2014-04, Vol.13 (1), p.e203-e203

Elsevier B.V

Texto completo disponível

Citações Citado por
3
255P Prognostic stratification capacity of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy
255P Prognostic stratification capacity of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

255P Prognostic stratification capacity of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy

Roussot, N. ; Constantin, G. ; Desmoulins, I. ; Kaderbhai, C. ; Hennequin, A. ; Mayeur, D. ; Ilie, S.M. ; Arnould, L. ; Bertaut, A. ; Eymard, J-C. ; Jouannaud, C. ; Savoye, A.M. ; Yazbek, G. ; Allouache, D. ; Delcambre, C. ; Hrab, I. ; Levy, C. ; Djezzer, C. Segura ; Deblock, M. ; Ladoire, S.

Annals of oncology, 2023-10, Vol.34, p.S285-S285 [Periódico revisado por pares]

Elsevier Ltd

Sem texto completo

Citações Citado por
4
335PBreast cancer (BC) treatment (tx) with everolimus (EVE) and exemestane (EXE) in hormone receptor positive (HR+)/ HER2-negative (HER2−) postmenopausal women: Final analysis of the French observational TANGO study
335PBreast cancer (BC) treatment (tx) with everolimus (EVE) and exemestane (EXE) in hormone receptor positive (HR+)/ HER2-negative (HER2−) postmenopausal women: Final analysis of the French observational TANGO study
Material Type:
Artigo 		Adicionar ao Meu Espaço

335PBreast cancer (BC) treatment (tx) with everolimus (EVE) and exemestane (EXE) in hormone receptor positive (HR+)/ HER2-negative (HER2−) postmenopausal women: Final analysis of the French observational TANGO study

Villanueva, C ; Yazbek, G ; Beuzeboc, P ; Viel, E ; Dohollou, N ; Luporsi, E ; Eymard, J-C ; Levy, E ; Mouret-Reynier, M-A ; Dourthe, L-M ; Malaurie, E ; Madelenat, M ; Denden, A ; Antoine, E-C

Annals of oncology, 2018-10, Vol.29 (suppl_8) [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Citações Citado por
5
372: Effect of addition of clonidine to local anesthetic mixture for peribulbar block in vitreoretinal surgery
372: Effect of addition of clonidine to local anesthetic mixture for peribulbar block in vitreoretinal surgery
Material Type:
Artigo 		Adicionar ao Meu Espaço

372: Effect of addition of clonidine to local anesthetic mixture for peribulbar block in vitreoretinal surgery

Yazbek-karam, V. ; Barakat, D. ; Abi nader, E. ; Karam, H. ; Habib, E. ; Abou chacra, C. ; Aouad, M. ; Cherfane, G.

Regional anesthesia and pain medicine, 2007-09, Vol.32 (5), p.22-22 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
6
455 Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing trans-rectal prostate biopsy
455 Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing trans-rectal prostate biopsy
Material Type:
Artigo 		Adicionar ao Meu Espaço

455 Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing trans-rectal prostate biopsy

Yazbek, Hanna M ; Robert, M ; Mark, R ; Gurvir, J ; Catherine, T ; David, L

European urology supplements : official journal of the European Association of Urology, 2014-04, Vol.13 (1), p.e455-e455

Elsevier B.V

Texto completo disponível

Citações Citado por
7
6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial
6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial

Pivot, Xavier, Prof ; Romieu, Gilles, MD ; Debled, Marc, MD ; Pierga, Jean-Yves, Prof ; Kerbrat, Pierre, Prof ; Bachelot, Thomas, MD ; Lortholary, Alain, MD ; Espié, Marc, MD ; Fumoleau, Pierre, Prof ; Serin, Daniel, MD ; Jacquin, Jean-Philippe, MD ; Jouannaud, Christelle, MD ; Rios, Maria, MD ; Abadie-Lacourtoisie, Sophie, MD ; Tubiana-Mathieu, Nicole, Prof ; Cany, Laurent, MD ; Catala, Stéphanie, MD ; Khayat, David, Prof ; Pauporté, Iris, PhD ; Kramar, Andrew, PhD

The lancet oncology, 2013-07, Vol.14 (8), p.741-748 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Kerbrat, Pierre ; Fumoleau, Pierre ; Jacquin, Jean-Philippe ; Abadie-Lacourtoisie, Sophie ; Cany, Laurent ; Khayat, David ; Paget-Bailly, Sophie ; Demarchi, F ; N'Guyen, T ; Stein, U ; Villanueva, C ; Guimont, I ; Lévy, E ; Delbaldo, C ; Pouessel, D ; Fournel-Fédérico, C ; Freyer, G ; Tartas, S ; Bons, F ; Cuvier, C ; Hajjaji, N ; Capitain, O ; Maillart, P ; Bonnefoi, H ; Durand, M ; Madranges, N ; Mauriac, L ; Durando, X ; Durieux, A ; Piperno-Neumann, S ; Tresca, P ; Ferrant, E ; Mayer, F ; Vanneuville, AC ; Servent, V ; Guastalla, JP ; Biron, P ; Dupuy-Brousseau, L ; Lancry, L ; Trédan, O ; Extra, JM ; Berton-Rigaud, D ; Ferrero, JM ; Largillier, R ; Gedoin, D ; Laguerre, B ; Lefeuvre, C ; Vauléon, E ; Tennevet, I ; Mefti-Lacheraf, F ; Dalenc, F ; André, F ; Domont, J ; Ezenfis, J ; Provençal, J ; Bellaiche-Miccio, C ; Boutan-Laroze, G ; Arsène, O ; Merad-Boudia, Z ; Orfeuvre, H ; Lamy, R ; Sarda, C ; Salles, B ; Cauvin, I ; Mangold, M ; Bourcier, A ; Geay, JF ; ElAmarti, R ; Combe, M ; Dauba, J ; Denizon, N ; Clavreul, G ; Goubely, Y ; Delecroix, V ; Ligeza-Poisson, V ; Leyronnas, C ; Teissier, E ; Bernard, O ; Pottier-Kyndt, V ; Drony, S ; Moriceau, M ; Besson, D ; Achille, E ; Moran-Ribon, A ; Moullet, I ; Couderc, B ; Burki, F ; Schaeffer, F ; Montcuquet, P ; Baumont, GA ; Gréget, S ; Ratoanina, JL ; Bonichon-Lamichhane, M ; Cartron, G ; Dupuis, O ; Ganem, G ; LeRol, A ; Antoine, EC ; Llory, JF ; Loiseau, D

The Lancet (British edition), 2019-06, Vol.393 (10191), p.2591-2598 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
881 - Urine biomarker profiling contains structure and predicts prostate cancer hormone therapy relapse
881 - Urine biomarker profiling contains structure and predicts prostate cancer hormone therapy relapse
Material Type:
Artigo 		Adicionar ao Meu Espaço

881 - Urine biomarker profiling contains structure and predicts prostate cancer hormone therapy relapse

Curley, H. ; Yazbek-Hanna, M. ; Hurst, R. ; Kumar, R. ; Mills, I. ; Schalken, J. ; Clark, J. ; Brewer, D. ; Cooper, C.

European journal of cancer (1990), 2016-07, Vol.61, p.S204-S204 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
10
A conquista do Mexico
A conquista do Mexico
Material Type:
Livro 		Adicionar ao Meu Espaço

A conquista do Mexico

Mustafa Yazbek

São Paulo Atica 1988

Localização: CDCC - Cent. Div. Científica e Cultural    (972 Y35c )(Acessar)

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (229)
  2. Livros  (52)
  3. Dissertações  (7)
  4. Reports  (4)
  5. Outros  (4)
  6. Resenhas  (3)
  7. Conjunto de Dados  (2)
  8. Recursos Textuais  (2)
  9. Anais de Congresso  (2)
  10. Produções Acadêmicas  (1)
  11. Imagens  (1)
  12. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1985  (10)
  2. 1985Até1993  (45)
  3. 1994Até2003  (30)
  4. 2004Até2013  (81)
  5. Após 2013  (142)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (176)
  2. Português  (100)
  3. Francês  (35)
  4. Japonês  (7)
  5. Espanhol  (2)
  6. Alemão  (1)
  7. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Yazbek, M
  2. Serro-Azul, L
  3. Yazbek, G
  4. Wolosker, N
  5. Pileggi, F

Neste Assunto:

  1. Science & Technology
  2. Life Sciences & Biomedicine
  3. Humans
  4. Female
  5. Male

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.